Dr. Anh Hoang Pham, MD, PhD

Dr. Pham practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Pham's NPI, 1366856460, was assigned on June 17, 2014. Dr. Pham graduated from Keck School of Medicine of USC in 2014. Dr. Pham holds Florida license ME149827.

Dr. Pham's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Pham's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Pham to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pham practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Pham's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Pham is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Pham's licenses on file in 2 states: Florida and California.

Dmand AI lists cataract, cataract surgery with lens implant, glaucoma, glaucoma surgery and secondary membranaous cataract surgery among the conditions Dr. Pham treats.

CMS data shows 441 Medicare services from Dr. Pham across 10 procedure codes in 2024, for 117 Medicare patients. Medicare paid $28,303 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Pham in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pham's median patient age at 74, with 57% women.

In 2024, Dr. Pham wrote 2,008 Medicare Part D claims for 284 patients. 61% of them were for generic drugs. CMS names the drug for 1,916 of them, across 22 drugs with 11 or more claims each, at $143,667 in total drug cost. In 2023, CMS named 1,020 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Pham for performance year 2024, reported as part of a group. Dr. Pham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of cataract surgery by Dr. Pham, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Pham, published from 2012 to 2023. The most frequent topics are Metabolomics and Software. Dr. Pham has published most often in Methods Mol Biol. Dr. Pham's most frequent co-authors are David Chan, MD and Anna K. Junk, MD.

CMS Open Payments shows 27 general payments to Dr. Pham from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,424.

Dr. Pham graduated from Keck School of Medicine of USC in 2014.

Dr. Pham is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.